Home

From TechCrunch

By Marina Temkin

February 12, 2025

Six months after raising $29M, Candid Health nabs another $52.5M to ease medical billing

news image

With over 1,000 insurance companies in the U.S., figuring out how to get paid by each company is a complex challenge for doctors and hospitals.


Each insurance may require slightly different information on medical claims, even for the same procedure. Incorrectly filed claims can lead to denied coverage, requiring manual resubmission and delayed payments.


According to Nick Perry, co-founder and CEO of Candid Health, most medical claim denials result from legacy billing system providers struggling to keep pace with the increasing complexities of modern healthcare.


After five years at Palantir, Perry founded Candid Health in 2019 with the goal of simplifying medical billing by automating claims submissions and eliminating manual work for billing teams.


Since then, the company has attracted a growing number of telehealth providers, including Allara, Nourish and Talkiatry, and has recently begun adding large physician groups as customers. In 2024, Candid’s revenue grew nearly 250%.


Investors noticed the company’s fast growth pace. On Wednesday, Candid announced that it raised a $52.5 million Series C led by Oak HC/FT and existing investors. The round comes six months after Candid’s $29 million Series B, which was led by 8VC with participation of returning backers First Round Capital, BoxGroup, and Y Combinator.


Perry built the company by drawing on his Palantir experience, where he witnessed the power of data analytics firsthand. Medical billing is ultimately a data engineer problem, he told TechCrunch.


“Legacy systems flag problems with claims, and send them back to providers to fix the claim,” Perry said. But Candid Health claims that it has developed, and continually refines, a sophisticated rules engine that allows providers to submit accurate claims to insurance companies on the first try.


So far, Candid hasn’t leaned into generative AI, but some of the latest funding will go towards implementing the latest machine learning techniques. For instance, AI can identify claim types consistently denied by insurers, enabling Candid’s system to correct those claims before they are submitted.


The company may eventually also build an AI-powered feature that can call insurances about denied claims. But the company’s ultimate goal is to avoid those calls altogether.


“There shouldn’t have to be a denial phone call,” Perry said. “It’s much better to just submit the claim correctly the first time.”


In addition to competing with legacy billing systems, many of which are built by electronic health record companies like Epic and Athenahealth, Candid Health competes with startups Apero and Adonis, which is backed by Point72 Ventures and General Catalyst.


View original article on techcrunch.com

Share:

Top Posts

news image

Minimalist Light Phone III launches March 27

Light, the maker of a minimalist phone designed to help consumers disconnect from smartphone distractions and social media, will launch its newest model, the Light Phone III, on March 27. This version of the device, like its older counterpart, offers a simple black-and-white display and necessary features like support for calls, texts, navigation, alarms, hotspots, a calendar, and more, including music. However, the upgraded device now ships with a 3.92-inch AMOLED display instead of an e-paper

Mar 13, 2025

news image

10 startups to watch from Y Combinator’s W25 Demo Day

One of Silicon Valley’s most storied startup accelerators, Y Combinator, held its Winter 2025 Demo Day on Wednesday, showcasing what its latest batch of 160 startups are cooking up. Some of Silicon Valley’s most successful startups – including Stripe, AirBnB, and Reddit – started out in a YC batch. Today, YC’s newer startups are focused on building the next big thing in AI. In this batch, we noticed a surprising number of startups creating tools to enhance other companies’ AI agents. Rather th

Mar 13, 2025

news image

5 ways TechCrunch Sessions: AI will fuel your AI growth

Less than three months until TechCrunch’s biggest AI event yet! If you’re shaping the future of AI, investing in the next game-changing innovation, or simply eager to dive deep into what’s next, TechCrunch Sessions: AI is the place to be. On June 5, Zellerbach Hall in UC Berkeley, will be buzzing with 1,200 AI experts, investors, and enthusiasts exchanging ideas, forging connections, and exploring the frontier of artificial intelligence. Secure your spot now and save up to $210 before ticket pr

Mar 13, 2025

Don't miss our latest news and updates. Subscribe to the newsletter

aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.

aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.

Research

Member

Backed by

© aVenture Investment Company, 2025. All rights reserved.

44 Tehama St, San Francisco, CA 94105

Privacy Policy

aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.

aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.

Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.